Australasian Biotechnology,
Volume 8 Number 5, September/October 1998, pp. 299-302
Regulatory Issues
Biotechnology Under the Spotlight - The Hazardous Substances and New Organisms
Act - 1996
Mark Christensen/Martin Williams
Code Number:AU98038
Sizes of Files:
Text: 18K
Graphics: No associated graphics files
This article examines the potential impact of the new Hazardous Substances and New
Organisms Act 1996 on the biotechnology industry in New Zealand. The purpose of the paper
is to provide an overview of the Act and, in particular, the need to obtain approvals under the
Act for genetic modifications. The procedures for processing of applications for approval are
explained. In particular, the implications of the extent of public involvement in the decision
making process for the industry are outlined, along with the approach the industry should take
in this new regulatory environment in light of public concerns about biotechnology, and in
particular genetically-modified foods. It is argued that, provided the right approach is taken,
the biotechnology industry should be able to take full advantage of this robust regulatory
system, to ensure that the benefits which the industry can provide to the economy are realised,
and the profile of the industry is enhanced.
Copyright 1998 Australian Biotechnology Association Ltd.
